🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

RecruitingNAAges 18 Years - 100 YearsAllUniversity of Kansas Medical Center
NCT06728436 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos. Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences . Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Over the age of 18 * Spanish and English-speaking people who identify as Latino * Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment * Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10) * Self-reports being able to read and write * Owns a cell phone with a flat fee, and uses it at least weekly for texting. Exclusion Criteria: * Participation in another wellbeing-related clinical trial * Cohabitation with another participant in the CuidaTEXT R01 Study * Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study * Participant plans to move to another country within seven months
💊

What it tests

  • CuidaTEXT
📍

Where

1 site
University of Kansas Medical Center
Fairway, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy